1.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 16 and over Sponsor: Other Protocol IDs: VGHUST98-P1-07, VGHIRB98-01-08, NCT00926757
|
|
2.
|
Phase: Phase IV Type: Health services research, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UKM-SF-042010, NCT01114165
|
|
3.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: H0901329, NCT01189409
|
|
4.
|
Phase: Phase IV Type: Supportive care Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: Par 06-0045, NCT01313247
|
|
5.
|
Phase: Phase III Type: Treatment Status: Active Age: 54 and under Sponsor: Other Protocol IDs: 0107M05202, MT2001-02, NCT00176930
|
|
6.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2007-0808, NCT00761618
|
|
7.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: EA4/031/09, NCT00884364
|
|
8.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VORI911, NCT00893555
|
|
9.
|
Phase: Phase III Type: Behavioral study, Supportive care Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: 176-25/kmo, NCT01035203
|
|
10.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EudraCT nr: 2009-015336-15, Protocol nr: 29462, NCT01164046
|
|
11.
|
Phase: Phase III Type: Supportive care Status: Active Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CR017188, JNS024ER-KAJ-C02, NCT01165281
|
|
12.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: V212-011, NCT01254630
|
|
13.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000696704, CRUK-KPS-2008-01, EU-21012, EUDRACT-2007-002080-27, ISRCTN-49116945, NCT01316744
|
|
14.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: GWCA0999, 2009-016529-32, NCT01337089
|
|
15.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CDR0000581078, U01CA121947, AMC-053, NCT00598169
|
|
16.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: FDA IND 100712, NCT00611208
|
|
17.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0711003269, NCT00785798
|
|
18.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: ARL-GT 2005, NCT00858793
|
|
19.
|
Phase: Phase II, Phase I Type: Diagnostic Status: Active Age: 16 and over Sponsor: Other Protocol IDs: SP-24513/DX-FLT-002, NCT01065805
|
|
20.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 060051, 06-C-0051, NCT00267865
|
|
21.
|
Phase: Phase II Type: Treatment Status: Active Age: Under 70 Sponsor: Other Protocol IDs: 2005LS048, UMN-0508M72589, UMN-MT2004-24, UMN-2005LS048, NCT00345865
|
|
22.
|
Phase: Phase II Type: Treatment Status: Active Age: 15 to 65 Sponsor: Other Protocol IDs: C-012A, NCT00561301
|
|
23.
|
Phase: Phase II Type: Supportive care Status: Active Age: 19 to 70 Sponsor: Other Protocol IDs: McG 0710, NCT00765466
|
|
24.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 75 and under Sponsor: NCI, Other Protocol IDs: 2212.00, NCI-2009-01244, U19AI096111, P01CA018029, NCT00968630
|
|
25.
|
Phase: Phase II Type: Treatment Status: Active Age: 0 to 26 Sponsor: Other Protocol IDs: L 10,321, NYMC 525, NCT01049854
|